PPIDT00185
Drug Information
| Name | Teicoplanin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB06149 |
| Type | small molecule |
| Indication | For the treatment of bacterial infections caused by susceptible microorganisms. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intramuscular; Intravenous |
|
| Solution | Parenteral |
200.000 mg
|
| Injection, solution | Intramuscular; Intravenous |
200 mg
|
| Injection, solution | Intramuscular; Intravenous |
400 mg
|
| Solution | Parenteral |
400.00 mg
|
| Injection, powder, for solution | Intramuscular; Intravenous |
400 mg
|
| Solution | Intravenous |
200.00 mg
|
| Solution | Parenteral |
200.00 mg
|
| Solution | Parenteral |
100.000 mg
|
| Injection, powder, for solution | Parenteral |
|
| Injection, solution | Intramuscular; Intravenous |
200 mg/3ml
|
| Injection, powder, for solution | Intramuscular; Intravenous |
200 mg
|
| Injection, solution | Intramuscular; Intravenous |
400 mg/3ml
|
| Injection, powder, lyophilized, for solution | Parenteral |
20000000 mg
|
| Injection, powder, for solution | Parenteral |
200 mg
|
| Injection, powder, for solution | Parenteral |
400 mg
|
| Powder, for solution | Oral; Parenteral |
200 mg
|
| Powder, for solution | Oral; Parenteral |
400 mg
|
| Powder, for solution | Oral; Parenteral |
|
| Solution | Oral |
|
| Injection, powder, for solution | Oral; Parenteral |
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
40000000 mg
|
| Injection, powder, for solution | — |
200 MG
|
| Injection, powder, for solution | — |
400 MG
|
| Injection, powder, for solution | Oral |
|
| Injection, powder, for solution; powder, for solution | Intramuscular; Intravenous; Oral |
100 MG
|
| Injection, powder, for solution; powder, for solution | Intramuscular; Intravenous; Oral |
200 MG
|
| Injection, powder, for solution; powder, for solution | Intramuscular; Intravenous; Oral |
400 MG
|
| Injection, powder, for solution | Oral; Parenteral |
100 MG
|
| Injection, powder, for solution | Oral |
200 MG
|
| Injection, powder, for solution | Oral |
400 MG
|
| Injection, powder, for solution | Oral; Parenteral |
200 MG
|
| Injection, powder, for solution | Oral; Parenteral |
400 MG
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
20000000 mg
|
| Injection, powder, for solution | Intramuscular; Intravenous |
|
| Injection | Intramuscular; Intravenous |
200 mg
|
| Injection | Intramuscular; Intravenous |
400 mg
|
| Solution | Intravenous |
200.000 mg
|
| Solution | Parenteral |
200 mg
|
| Solution | — |
200.00 mg
|
| Powder | — |
200 mg
|
| Powder | — |
200 mg/1vial
|
| Powder | — |
400 mg/1vial
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| No target records. | ||||||